business

Expect 50% returns in Glenmark Pharma: Tater

Expect 50% returns in Glenmark Pharma from current levels in next 12 months time, says Aashish Tater, Head of Research, Fortunewizard.com. We feel the expansion is going to continue even for next 3-4 quarters, which will be very rewarding for these kinds of companies. We have been bullish on Cipla, Glenmark, Wockhardt and we continue to do so.

first published: Nov 15, 2012 09:44 am